Article
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Current oncology reports - 1 Dec 2023
Brown Rebecca
Abstract excerpt
Neurofibromatosis type I (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis represent a diverse group of genetic tumor predisposition syndromes with a shared feature of tumors affecting the peripheral nerve sheaths. PURPOSE OF REVIEW: Many advancements have been made in understanding the biologic underpinnings of these conditions, and in 2016 the first drug was approved by the FDA to treat pediatric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
